NOVO.B.DK

261.45

+6.41%↑

GMAB.DK

1,715.5

-1.58%↓

HLUNB.DK

44.28

+3.07%↑

ZEAL.DK

303.6

-0.46%↓

AMBUB.DK

65.2

-1.36%↓

NOVO.B.DK

261.45

+6.41%↑

GMAB.DK

1,715.5

-1.58%↓

HLUNB.DK

44.28

+3.07%↑

ZEAL.DK

303.6

-0.46%↓

AMBUB.DK

65.2

-1.36%↓

NOVO.B.DK

261.45

+6.41%↑

GMAB.DK

1,715.5

-1.58%↓

HLUNB.DK

44.28

+3.07%↑

ZEAL.DK

303.6

-0.46%↓

AMBUB.DK

65.2

-1.36%↓

NOVO.B.DK

261.45

+6.41%↑

GMAB.DK

1,715.5

-1.58%↓

HLUNB.DK

44.28

+3.07%↑

ZEAL.DK

303.6

-0.46%↓

AMBUB.DK

65.2

-1.36%↓

NOVO.B.DK

261.45

+6.41%↑

GMAB.DK

1,715.5

-1.58%↓

HLUNB.DK

44.28

+3.07%↑

ZEAL.DK

303.6

-0.46%↓

AMBUB.DK

65.2

-1.36%↓

Search

Coloplast A-S (Class B)

Închisă

413.5 -1.36

Rezumat

Modificarea prețului

24h

Curent

Minim

412.8

Maxim

415.6

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.492

60.328

EPS

6.32

Randament dividend

5.28

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.28%

2.24%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-21B

98B

Deschiderea anterioară

414.86

Închiderea anterioară

413.5

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 apr. 2026, 21:14 UTC

Evenimente importante

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 apr. 2026, 21:14 UTC

Evenimente importante

Week Ahead for FX, Bonds: Major Central Bank -2-

24 apr. 2026, 19:19 UTC

Achiziții, Fuziuni, Preluări

Intertek Group Rejects EQT's Revised Offer

26 apr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 apr. 2026, 23:44 UTC

Câștiguri

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 apr. 2026, 23:44 UTC

Câștiguri

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 apr. 2026, 23:36 UTC

Market Talk
Evenimente importante

Gold Falls Amid Dollar's Strength -- Market Talk

26 apr. 2026, 23:33 UTC

Market Talk
Evenimente importante

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 apr. 2026, 05:12 UTC

Câștiguri

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 apr. 2026, 05:12 UTC

Câștiguri

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 apr. 2026, 05:12 UTC

Câștiguri

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 apr. 2026, 05:12 UTC

Câștiguri

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 apr. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Scoring the Cook Era -- Barrons.com

24 apr. 2026, 20:51 UTC

Achiziții, Fuziuni, Preluări

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr. 2026, 20:50 UTC

Market Talk
Evenimente importante

Financial Services Roundup: Market Talk

24 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

24 apr. 2026, 20:39 UTC

Achiziții, Fuziuni, Preluări

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr. 2026, 20:09 UTC

Câștiguri

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 apr. 2026, 19:48 UTC

Market Talk
Evenimente importante

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 apr. 2026, 19:25 UTC

Achiziții, Fuziuni, Preluări

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr. 2026, 19:25 UTC

Achiziții, Fuziuni, Preluări

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 apr. 2026, 19:22 UTC

Câștiguri

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 apr. 2026, 19:06 UTC

Câștiguri

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 apr. 2026, 19:05 UTC

Market Talk

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 apr. 2026, 18:30 UTC

Achiziții, Fuziuni, Preluări

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 apr. 2026, 18:28 UTC

Achiziții, Fuziuni, Preluări

Intertek Rejects Revised EQT Offer

24 apr. 2026, 18:12 UTC

Market Talk

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 apr. 2026, 18:06 UTC

Market Talk

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 apr. 2026, 17:42 UTC

Câștiguri

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 apr. 2026, 17:28 UTC

Câștiguri

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat